The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes

NCT00353834 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Exenatide
DRUG: Glargine Insulin

Sponsor

Joslin Diabetes Center

Collaborators

[object Object]
[object Object]